Alnylam Pharmaceuticals, Inc. (ALNY)

306.06 +0.52 (+0.17%) USD  |  NASDAQ  |  Apr 27, 14:10
More

Alnylam Pharmaceuticals EPS Diluted (TTM) : 2.257 for Dec. 31, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Pfizer Inc. 1.355
Gilead Sciences, Inc. 6.782
Ionis Pharmaceuticals, Inc. -2.467
Eli Lilly & Co. 22.59
Sarepta Therapeutics, Inc. -8.438